banner
BTK inhibitor HM61713, Purity ≥98%

Cat. No.: X24-06-ZQ488

BTK inhibitor HM61713, Purity ≥98%

Synonym: 1353550-13-6; BTK inhibitor; HM 61713; HM-61713; BI-1482694; BI1482694; BI 1482694

  • MDL: MFCD29918158
  • CAS Number: 1353550-13-6
  • Compound CID: 54758501
Product Size
5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
HM61713, soluble in DMSO and ethanol and insoluble in water, is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells. It targets mutant EGFR.
Molecular Weight
486.59
Molecular Formula
C26H26N6O2S
Targets
mutant EGFR
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 95 mg/mL (195.23 mM); Water: Insoluble; Ethanol: 23 mg/mL (47.26 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
HM61713 is studied as a BTK inhibitor for applications in immune disorders and B-cell malignancies.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0